The role of HIPK2 in the pathogenesis of therapy-related myelodysplastic syndrome with del7q
2021

Overview
The Vera and Joseph Dresner Foundation granted University of Texas – MD Anderson Cancer Center a $232,643 grant over two years for early career investigator Dr. Koichi Takahashi.

Details
Dr. Takahashi with the support of his mentor, Dr. Andrew Futreal, aim to understand the pathogenesis of therapy-related MDS with deletion 7q by investigating the role of HIPK2 in cellular fitness and differentiation of hematopoietic cells.

Learn more about University of Texas – MD Anderson Cancer Center.